Xeloda in Adjuvant Colon Cancer Therapy (X-ACT) trial: overview of efficacy, safety, and cost-effectiveness. 30. Mai 2006 Twelves, C.J., 2006. Clin Colorectal Cancer 6, 278–287. Abstract Capecitabine as adjuvant treatment for stage III colon cancer. Twelves, C., Wong, A., Nowacki, M.P., Abt, M., Burris, H., Carrato, A., Cassidy, J., Cervantes, A., Fagerberg, J., Georgoulias, V., Husseini, F., Jodrell, D., Koralewski,… Weiterlesen Bendamustine versus chlorambucil in treatment-naive patients with B-cell chronic lymphocytic leukemia (B-CLL): Results of an international phase III study. Knauf, W.U., Lissichkov, T., Aldaoud, A., Herbrecht, R., Liberati, A.M., Loscertales, J., Juliusson, G., Dittrich, C., Merkle, K., 2007. Blood 110(11), 2043. Weiterlesen